Dow Up0.09% Nasdaq Down0.02%

Medtronic, Inc. (MDT)

63.36 Down 0.16(0.25%) 4:00PM EDT
|After Hours : 63.36 0.00 (0.00%) 4:42PM EDT
ProfileGet Profile for:
Medtronic, Inc.
710 Medtronic Parkway
Minneapolis, MN 55432
United States - Map
Phone: 763-514-4000

Index Membership:N/A
Industry:Medical Appliances & Equipment
Full Time Employees:49,247

Business Summary 

Medtronic, Inc. manufactures and sells device-based medical therapies worldwide. It operates through three segments: Cardiac and Vascular Group, Restorative Therapies Group, and Diabetes Group. The Cardiac and Vascular Group’s products include pacemakers; insertable cardiac monitors; implantable defibrillators; leads and delivery systems; ablation products; electrophysiology catheters; products for the treatment of atrial fibrillation; information systems for the management of patients with cardiac rhythm disease management devices; products to reduce surgical site infections; coronary and peripheral stents and related delivery systems; therapies for uncontrolled hypertension; endovascular stent graft systems; heart valve replacement technologies; cardiac tissue ablation systems; and open heart and coronary bypass grafting surgical products. The Restorative Therapies Group offers products for various areas of the spine; bone graft substitutes; biologic products; trauma, implantable neurostimulation therapies, and drug delivery systems for the treatment of chronic pain, movement disorders, obsessive-compulsive disorder, overactive bladder, urinary retention, fecal incontinence, and gastroparesis; products to treat conditions of the ear, nose, and throat; and systems that incorporate advanced energy surgical instruments. It also manufactures and sells image-guided surgery and intra-operative imaging systems. The Diabetes Group’s products include insulin pumps; continuous glucose monitoring systems; insulin pump consumables; and Web-based therapy management software solutions. The company serves hospitals, physicians, clinicians, and patients in approximately 140 countries. Medtronic, Inc. was founded in 1949 and is headquartered in Minneapolis, Minnesota.

Key Statistics

Company Websites 
Home Page
Search Yahoo! for:
More on Medtronic, Inc.

Corporate Governance 
Medtronic, Inc.’s ISS Governance QuickScore as of Aug 1, 2014 is 7. The pillar scores are Audit: 10; Board: 8; Shareholder Rights: 7; Compensation: 2.
Brought to you by Institutional Shareholder Services (ISS)

Key Executives 
Mr. Omar S. Ishrak , 58
Chairman and Chief Exec. Officer
Mr. Gary L. Ellis , 57
Chief Financial Officer, Principal Accounting Officer and Exec. VP
Ms. Carol A. Surface Ph.D., 48
Chief HR Officer and Sr. VP
Mr. Christopher James O'Connell , 47
Exec. VP and Group Pres of Restorative Therapies Group
Mr. Michael J. Coyle , 51
Exec. VP and Group Pres of Cardiac & Vascular Group
Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders